Vimarsana
Biggest News Aggregation in the World

Exela Pharma Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exela Pharma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exela Pharma Sciences Today - Breaking & Trending Today

Global Super Generics Market Report 2024: A $200 Billion - Vimarsana News

Global Super Generics Market Report 2024: A $200 Billion

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The

Super Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest Study - Vimarsana News

Super Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest Study

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Super Generics Market –By Therapeutic Area...

Exela Pharma recalls 400K drugs - Vimarsana News

Exela Pharma recalls 400K drugs

Exela Pharma Sciences is recalling over 415,000 drug vials due to possible presence of silicone. This includes 8.4% sodium bicarbonate and midazolam.

Exela Recalls Three Injectable Products Due to Presence of Particulate Matter - Vimarsana News

Exela Recalls Three Injectable Products Due to Presence of Particulate Matter

Exela Pharma Sciences is recalling 3 injectable products due to the potential presence of particulate matter.

Source: empr.com
COVID and Flu Vaccine Risk; Medicare Advantage Fraud; $1.4B Missing Health Funds - Vimarsana News

COVID and Flu Vaccine Risk; Medicare Advantage Fraud; $1.4B Missing Health Funds

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff